Access cutting-edge lung cancer treatment through this clinical trial at a research site in Sacramento. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Sacramento at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This is a Phase 3 Randomized, double-blind, Multiregional Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung Cancer. The primary endpoint is overall survival and progression free survival assessed by investigator. The key secondary endpoints include response and safety.
Sponsor: Summit Therapeutics
Check if you qualify for this lung cancer clinical trial in Sacramento, CA
If you're searching for lung cancer treatment options in Sacramento, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sacramento research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.